As of 3:59pm ET
| +0.015 / +0.03%|
The 18 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 43.15, with a high estimate of 56.42 and a low estimate of 36.35. The median estimate represents a -17.05% decrease from the last price of 52.03.
The current consensus among 21 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.